Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Other Non-Current Assets (2023 - 2025)

Immunome's Other Non-Current Assets history spans 3 years, with the latest figure at $210000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 110.0% year-over-year to $210000.0; the TTM value through Dec 2025 reached $210000.0, up 110.0%, while the annual FY2025 figure was $210000.0, 110.0% up from the prior year.
  • Other Non-Current Assets reached $210000.0 in Q4 2025 per IMNM's latest filing, roughly flat from $210000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $210000.0 in Q2 2025 to a low of $100000.0 in Q1 2023.
  • Average Other Non-Current Assets over 3 years is $127500.0, with a median of $100000.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: changed 0.0% in 2024, then skyrocketed 110.0% in 2025.
  • A 3-year view of Other Non-Current Assets shows it stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then surged by 110.0% to $210000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMNM's Other Non-Current Assets are $210000.0 (Q4 2025), $210000.0 (Q3 2025), and $210000.0 (Q2 2025).